Page last updated: 2024-08-23

bromocriptine and Neuroleptic Malignant Syndrome

bromocriptine has been researched along with Neuroleptic Malignant Syndrome in 115 studies

Research

Studies (115)

Timeframe	Studies, this research(%)	All Research%
pre-1990	37 (32.17)	18.7374
1990's	41 (35.65)	18.2507
2000's	26 (22.61)	29.6817
2010's	6 (5.22)	24.3611
2020's	5 (4.35)	2.80

Authors

Authors	Studies
Kamiyama, T; Mizuno, T; Suzuki, A; Suzuki, M; Takahashi, R	1
Irfan, N; Khalid, Z; Zaidi, S	1
Angulo, NY; Castaño, PA; Gómez, CC; Quintero, S	1
Elyasi, F; Heydari, F; Sadati, S	1
Apramian, A; Kajani, R; Liu, A; Ubhayakar, N; Vega, A; Xu, P	1
Bc, M; Chatterjee, SS; Das, S; Kartha, A; Purushothaman, ST; Rajan, V	1
Barahona-Corrêa, JB; Neves, A; Oliveira-Maia, AJ; Velosa, A	1
Fraile, S; García, B; Hidalgo, FJ; Lopez, E	1
Ikushima, G; Kameda, K; Koinuma, M; Shoko, T; Takahashi, K; Watarai, K	1
Graudins, A; Green, D; Morris, E	1
Gillman, K	1
Gillman, PK	1
Onder, E; Tural, U	1
Kuhlmann, A; Müller, T; Reimer, J	1
Reingardiene, D	1
Bhan, S; Kulkarni, V; Mehta, Y; Sharma, KK; Suri, ML; Trehan, N	1
Alkin, T; Demopulos, CM; Ozerdem, A; Sagduyu, K; Yildiz, A	1
Nishijima, K	1
Anand, JS; Chodorowski, Z; Rutkowski, P	1
Ananth, J; Burgoyne, K; Gunatilake, S; Parameswaran, S; Sidhom, T	1
Bozoklu, A; Dener, C; Koçak, OM; Sen, M; Tunca, A	1
Andrade, CR; Mendhekar, DN	1
Amaro, S; Gaig, C; Gómez-Choco, MJ; Martí, MJ; Tolosa, E	1
Nagamine, M; Nomura, S; Sakurai, Y; Sanga, M; Takahashi, R; Yoshino, A	1
Jiloha, RC; Mendhekar, DN	1
Collumbien, EC; Smidt, MH	1
Bildik, T; Ercan, ES; Erermis, S; Gockay, A; Karasoy, H; Tamar, M	1
Akan, M; Akdede, B; Akvardar, Y; Kosehasanogullari, SG; Tunca, Z	1
Caroff, SN; Keck, PE; Strawn, JR	1
Santens, P; Vancaester, E	1
Furuno, T; Kawanishi, C; Kishida, I	1
Joshi, AS; Khobragade, AK; Patel, AL; Sahastrabuddhe, GS; Shaikh, WA; Soni, HG	1
Archambeaud-Mouveroux, F; Dallet, A; Papapietro, P; Parini, M; Vincent, D	1
Rónai, L; Wagner, G	1
Marken, PA; Schneiderhan, ME	1
Abraham, OC; Archana, S; Cherian, AM; Kurien, T; Rajeev, KK	1
Minnema, AM; Reddig, S; Tandon, R	1
Becker, BN; Ismail, N	1
Kornhuber, J; Weller, M	1
Byrd, C	1
Cervero Jiménez, M; Fernández Ballesteros, A; Marco Martínez, J; Martín Joven, A	1
Aibiki, M; Chikano, S; Ogli, K; Onaka, A; Shirakawa, Y; Yokono, S	1
Borzotta, AP; Galloway, GQ; Hirst, R	1
Alted Lopez, E; Ambros Checa, A; Caballero Cubedo, R; Perez-Vela, JL; Sanchez Casado, M; Sanchez-Izquierdo Riera, JA	1
Ganelin, L; Lichtenberg, PS; Marcus, EL; Munter, RG	1
Grande Rodríguez, S; Real Rodríguez, B; Ruibal, JL; Sueiro Pita, B	1
del Toro Cervera, J; García Castaño, J; Muiño Miguez, A; Segado Soriano, A	1
Freedman, MD	1
Batalla, A; Cruz, JM; Cutrin, C; Gómez, XA; Pato, M	1
Deppe, S; Epperly, N; Friedman, B; Law, E; Orlet, H; Still, J	1
Sunohara, N	1
Miyoshi, T; Motomura, S; Osoegawa, M; Tamura, K; Yamanaka, H	1
Barron, TF; Dayner, J; Trasmonte, J	1
Koyama, T; Kusumi, I	1
Geurts, M; Maloteaux, JM; Noël, F	1
Privette, T; Stanfield, SC	1
Chew, EL; Ong, KC; Ong, YY	1
Susman, VL	1
Agrawal, M; Krishnan, P; Niranjan, S; Patel, U	1
Lee, MK; Loh, TG; Ong, SB; Tan, CT	1
Chiang, WK; Herschman, Z	1
Chaudhry, HR; Javed, A	1
Becker, H; Bittkau, S; Przuntek, H; Schröder, J; Sczesni, B; Truong, DD; von Baumgarten, F	1
Davis, JM; Janicak, PG; Sakkas, P; Wang, ZY	1
Retamal, P	1
Kanchanapongkul, J	1
Patkar, AA; Shah, LP	1
Mazurek, MF; Rosebush, PI; Stewart, T	1
Disch, M; Manheimer, E; Nierenberg, D; Patterson, J; Ross, J; Silvestri, G; Summerhill, E	1
Misra, A	1
Epperly, TD; Leo, KU; McGlaughlin, VG	1
Mazurek, MF; Rosebush, PI	1
Colardyn, F; De Reuck, J; Van Aken, J; Van Landegem, W	1
Keck, PE; McElroy, SL; Pope, HG; Seeler, DC	1
Baca, L; Martinelli, L	1
Delerue, O; Destée, A	1
Chinyanga, HM; Constantinou, E; Haisma, HJ	1
Björk, E; Hallberg, A; Martinussen, HJ; Trost, AC	1
Bhaskaran, R; Kunju, PA; Nair, KR	1
Hippius, H; Spiess-Kiefer, C	1
Adityanjee, PD; Chawla, HM	1
Avasthi, A; Giridhar, C; Singh, SP	1
Lazarus, A	2
Jeste, DV; Sewell, DD	1
Goldwasser, HD; Hooper, JF; Spears, NM	1
Mueller, PS	1
Levenson, JL	1
Keltner, NL; McIntyre, CW	1
Gorelick, PB; Greenberg, MS	1
Munitz, H; Shalev, A	1
Dick, P; Schulz, P	1
Bentsen, BS; Gillette, GM; Haggerty, JJ	1
Donovan, K; Fahn, S; Gross, J; Sczesni, B; Truong, DD; van Bakel, A; Wiley, MK	1
Olmsted, TR	1
Goldwasser, HD; Hooper, JF	1
Guerrero, RM; Shifrar, KA	1
Andrade, NN	1
Herjanic, M; Schvehla, TJ	1
Arora, A; Kapoor, SK; Malhotra, OP; Misra, A	1
Colvin, S; Lieberman, A; Pasternack, P	1
Rampertaap, MP	1
Abbott, RJ; Loizou, LA	1
Arana, GW; Cahill, C	1
Janati, A; Webb, RT	1
Dhib-Jalbut, S; Hesselbrock, R; Means, ED; Mouradian, MM	1
Baxter, LR; Guzé, BH	1
Addonizio, G; Susman, VL	1
Van Haren, J; Vincent, FM; Zimmerman, JE	1
Elderson, A; Verhoeven, WM	1
Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G	1
Ciolino, C; Rosse, R	1
Lucid, EJ; Martin, ML; Walker, RW	1
Elderson, A; Verhoeven, WM; Westenberg, HG	1

Reviews

20 review(s) available for bromocriptine and Neuroleptic Malignant Syndrome

Article	Year
[Neuroleptic malignant syndrome]. Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:1 Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis	2002
[Neuroleptic malignant syndrome]. Ryoikibetsu shokogun shirizu, 2003, Issue:38 Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Diazepam; Dopamine D2 Receptor Antagonists; Electroconvulsive Therapy; Fluid Therapy; Humans; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Receptors, Dopamine D2; Reference Standards; Secondary Prevention	2003
Neuroleptic malignant syndrome. The American journal of psychiatry, 2007, Volume: 164, Issue:6 Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Dantrolene; Diagnosis, Differential; Dopamine; Electroconvulsive Therapy; Female; Humans; Lorazepam; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Risk Factors	2007
[Drug-induced neuroleptic malignant syndrome]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8 Topics: Biomarkers; Bromocriptine; Creatine Kinase, MM Form; Cytochrome P-450 CYP2D6; Dantrolene; Diagnosis, Differential; Dopamine Agonists; Dopamine Antagonists; Humans; Neuroleptic Malignant Syndrome; Polymorphism, Genetic; Psychotropic Drugs; Reference Standards; Risk Factors; Time Factors	2007
[The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam]. Anales espanoles de pediatria, 1996, Volume: 44, Issue:1 Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Dantrolene; Diazepam; Drug Therapy, Combination; Haloperidol; Humans; Imipramine; Lorazepam; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Time Factors	1996
Neuroleptic malignant syndrome and acute myocardial infarction: case report and review. Maryland medical journal (Baltimore, Md. : 1985), 1997, Volume: 46, Issue:7 Topics: Antipsychotic Agents; Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Myocardial Infarction; Neuroleptic Malignant Syndrome; Thioridazine	1997
[Toxic and adverse neurological effects of anti-parkinsonian drugs]. Ryoikibetsu shokogun shirizu, 1999, Issue:27 Pt 2 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced; Substance-Related Disorders	1999
Algorithms for the treatment of acute side effects induced by neuroleptics. Psychiatry and clinical neurosciences, 1999, Volume: 53 Suppl Topics: Algorithms; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Japan; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Treatment Outcome	1999
Clinical management of neuroleptic malignant syndrome. The Psychiatric quarterly, 2001,Winter, Volume: 72, Issue:4 Topics: Bromocriptine; Carbidopa; Dopamine Agonists; Drug Combinations; Electroconvulsive Therapy; Guidelines as Topic; Humans; Levodopa; Neuroleptic Malignant Syndrome; Physical Therapy Specialty	2001
[Neuroleptic malignant syndrome]. Revista medica de Chile, 1990, Volume: 118, Issue:6 Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrome	1990
Neuroleptic malignant syndrome: a report of a case and review of the literature. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1991, Volume: 74, Issue:10 Topics: Adult; Antipsychotic Agents; Bromocriptine; Chronic Disease; Humans; Male; Neuroleptic Malignant Syndrome; Thailand	1991
Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome. Clinical pharmacology and therapeutics, 1991, Volume: 50, Issue:5 Pt 1 Topics: Bromocriptine; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrome	1991
Neuroleptic malignant syndrome. Hospital & community psychiatry, 1989, Volume: 40, Issue:12 Topics: Amantadine; Brain; Bromocriptine; Dantrolene; Humans; Neuroleptic Malignant Syndrome; Prognosis	1989
Neuroleptic malignant syndrome: a review. Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology, 1989, Volume: 9, Issue:3 Topics: Bromocriptine; Dantrolene; Diagnosis, Differential; Heat Exhaustion; Humans; Neuroleptic Malignant Syndrome; Recurrence; Risk Factors	1989
Neuroleptic malignant syndrome. Psychosomatics, 1985, Volume: 26, Issue:8 Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Female; Humans; Male; Neuroleptic Malignant Syndrome; Receptors, Dopamine; Substance Withdrawal Syndrome	1985
Neuroleptic malignant syndrome. The American journal of psychiatry, 1985, Volume: 142, Issue:10 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bromocriptine; Child; Dantrolene; Diagnosis, Differential; Dopamine; Dopamine Antagonists; Female; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Receptors, Dopamine; Rhabdomyolysis; Schizophrenia	1985
The neuroleptic malignant syndrome: agent and host interaction. Acta psychiatrica Scandinavica, 1986, Volume: 73, Issue:4 Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Carbidopa; Child; Child, Preschool; Dantrolene; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Leukocytosis; Male; Middle Aged; Neuroleptic Malignant Syndrome	1986
Neuroleptic malignant syndrome. Southern medical journal, 1986, Volume: 79, Issue:3 Topics: Adolescent; Adult; Benztropine; Bromocriptine; Catatonia; Child; Child, Preschool; Diagnosis, Differential; Female; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia, Paranoid; Time Factors	1986
Neuroleptic malignant syndrome. The British journal of psychiatry : the journal of mental science, 1986, Volume: 148 Topics: Adult; Amantadine; Animals; Body Temperature; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Humans; Muscle Rigidity; Neuroleptic Malignant Syndrome; Rats	1986
Current concepts. Neuroleptic malignant syndrome. The New England journal of medicine, 1985, Jul-18, Volume: 313, Issue:3 Topics: Amantadine; Basal Ganglia Diseases; Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Drug Interactions; Heat Exhaustion; Humans; Malignant Hyperthermia; Monoamine Oxidase Inhibitors; Neuroleptic Malignant Syndrome; Parasympatholytics	1985

Other Studies

95 other study(ies) available for bromocriptine and Neuroleptic Malignant Syndrome

Article	Year
Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report. The American journal of case reports, 2022, May-06, Volume: 23 Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; BNT162 Vaccine; Bromocriptine; COVID-19; Dantrolene; Humans; Hydrocortisone; Male; Middle Aged; Neuroleptic Malignant Syndrome; Vaccination; Valproic Acid	2022
Neuroleptic Malignant Syndrome with Normal Creatine Phosphokinase Levels: An Atypical Presentation. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2022, Volume: 32, Issue:4 Topics: Antipsychotic Agents; Benzodiazepines; Bromocriptine; Creatine Kinase; Fever; Humans; Male; Neuroleptic Malignant Syndrome	2022
Neuroleptic malignant syndrome associated with acute organophosphate poisoning: Case report Biomedica : revista del Instituto Nacional de Salud, 2022, 09-02, Volume: 42, Issue:3 Topics: Antipsychotic Agents; Bromocriptine; Chlorpyrifos; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Organophosphate Poisoning	2022
The management challenges of a case with Flupentixol-induced neuroleptic malignant syndrome. Neuropsychopharmacology reports, 2023, Volume: 43, Issue:1 Topics: Antipsychotic Agents; Bromocriptine; Flupenthixol; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders	2023
Neuroleptic malignant syndrome in a COVID-19 patient. Brain, behavior, and immunity, 2020, Volume: 88 Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coronavirus Infections; COVID-19; Dantrolene; Dopamine Agonists; Enzyme Inhibitors; Haloperidol; Humans; Hydroxychloroquine; Intensive Care Units; Leukocytosis; Lymphopenia; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Rhabdomyolysis; SARS-CoV-2; Schizophrenia	2020
Oral Asenapine overdose leading to Neuroleptic Malignant Syndrome (NMS). Asian journal of psychiatry, 2017, Volume: 30 Topics: Administration, Oral; Adult; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Dibenzocycloheptenes; Dopamine Agonists; Drug Overdose; Fluid Therapy; GABA Modulators; Heterocyclic Compounds, 4 or More Rings; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Valproic Acid	2017
Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach. BMJ case reports, 2019, Jun-17, Volume: 12, Issue:6 Topics: Acute Kidney Injury; Adult; Anticonvulsants; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Female; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Renal Dialysis; Treatment Outcome	2019
[Possible malignant neuroleptic syndrome associated with aripiprazole and imipramine and treated with bromocriptine]. Medicina clinica, 2013, Sep-21, Volume: 141, Issue:6 Topics: Antipsychotic Agents; Aripiprazole; Bromocriptine; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Frontotemporal Dementia; Humans; Imipramine; Lorazepam; Male; Mental Disorders; Middle Aged; Neuroleptic Malignant Syndrome; Oxygen Inhalation Therapy; Piperazines; Quinolones; Respiration, Artificial; Respiratory Insufficiency	2013
Pharmaceutical Approach for the Diagnosis and Treatment of Malignant Syndrome: A Case Study. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2016, Volume: 136, Issue:6 Topics: Administration, Oral; Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Drug Therapy, Combination; Haloperidol; Humans; Hydroxyzine; Infusions, Intravenous; Interdisciplinary Communication; Male; Neuroleptic Malignant Syndrome; Patient Care Team; Pharmaceutical Services; Treatment Outcome; Young Adult	2016
Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2009, Volume: 5, Issue:1 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Chlorpromazine; Citalopram; Combined Modality Therapy; Dopamine Agonists; Drug Overdose; Female; Humans; Hypnotics and Sedatives; Hypothermia, Induced; Infusions, Intravenous; Midazolam; Neuroleptic Malignant Syndrome; Olanzapine; Respiration, Artificial; Treatment Outcome	2009
In response to Morris et al.'s "Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine". Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2009, Volume: 5, Issue:4 Topics: Antipsychotic Agents; Benzodiazepines; Bromocriptine; Chlorpromazine; Disease Progression; Dopamine Agonists; Drug Overdose; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Serotonin Receptor Agonists; Treatment Outcome	2009
The nature of hyperthermia in neuroleptic malignant syndrome and the use of bromocriptine. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2010, Volume: 6, Issue:2 Topics: Bromocriptine; Dopamine Agonists; Humans; Malignant Hyperthermia; Neuroleptic Malignant Syndrome	2010
Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death. Psychiatry and clinical neurosciences, 2010, Volume: 64, Issue:1 Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Data Interpretation, Statistical; Death; Female; Hormone Antagonists; Humans; Male; Mental Disorders; Middle Aged; Neuroleptic Malignant Syndrome; Risk Factors; Young Adult	2010
Neuroleptic malignant-like syndrome after rapid switch from bromocriptine to pergolide. Parkinsonism & related disorders, 2002, Volume: 9, Issue:2 Topics: Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Pergolide	2002
Neuroleptic malignant syndrome: uncommon postoperative diagnostic dilemma. Asian cardiovascular & thoracic annals, 2002, Volume: 10, Issue:4 Topics: Aged; Bromocriptine; Coronary Artery Bypass; Coronary Artery Disease; Dementia; Diagnosis, Differential; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Postoperative Complications	2002
Neuroleptic malignant syndrome: a case that may shed new light into the etiology and treatment. The Australian and New Zealand journal of psychiatry, 2003, Volume: 37, Issue:4 Topics: Acute-Phase Proteins; Adult; Antipsychotic Agents; Bromocriptine; Clopenthixol; Dopamine Agonists; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome; Thioridazine	2003
[Neuroleptic malignant syndrome]. Przeglad lekarski, 2003, Volume: 60, Issue:4 Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Respiratory Insufficiency	2003
Neuroleptic malignant syndrome and atypical antipsychotic drugs. The Journal of clinical psychiatry, 2004, Volume: 65, Issue:4 Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Clozapine; Dantrolene; Dibenzothiazepines; Dopamine Agonists; Female; Humans; Intubation; Male; MEDLINE; Mental Disorders; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Olanzapine; Quetiapine Fumarate; Respiration, Artificial; Risperidone; Treatment Outcome	2004
Neuroleptic malignant syndrome after an emergency operation for acute appendicitis perforation. Canadian journal of surgery. Journal canadien de chirurgie, 2004, Volume: 47, Issue:6 Topics: Acute Disease; Anesthetics, General; Appendectomy; Appendicitis; Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Neuromuscular Blocking Agents; Treatment Outcome	2004
Neuroleptic malignant syndrome with promethazine. The Australian and New Zealand journal of psychiatry, 2005, Volume: 39, Issue:4 Topics: Adult; Antipsychotic Agents; Bromocriptine; Dopamine Agonists; Female; Humans; Neuroleptic Malignant Syndrome; Promethazine	2005
Parkinsonism-hyperpyrexia syndrome not related to antiparkinsonian treatment withdrawal during the 2003 summer heat wave. Journal of neurology, 2005, Volume: 252, Issue:9 Topics: Aged; Antiparkinson Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Fever of Unknown Origin; Heat Stroke; Humans; Infections; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Parkinsonian Disorders	2005
Exacerbating factors in neuroleptic malignant syndrome: comparisons between cases with death, sequelae, and full recovery. Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:5 Topics: Aged; Antipsychotic Agents; Body Temperature; Bromocriptine; Cause of Death; Creatine Kinase; Dantrolene; Dopamine Agonists; Female; Humans; Japan; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Retrospective Studies; Risk Factors	2005
Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation. The Australian and New Zealand journal of psychiatry, 2005, Volume: 39, Issue:10 Topics: Adult; Anti-Anxiety Agents; Antiparkinson Agents; Antipsychotic Agents; Bromocriptine; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Haloperidol; Humans; Lorazepam; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia; Substance Withdrawal Syndrome	2005
[A cocaine-induced variant of the neuroleptic malignant syndrome. A case study]. Tijdschrift voor psychiatrie, 2006, Volume: 48, Issue:5 Topics: Bromocriptine; Cocaine; Dantrolene; Dopamine Agonists; Humans; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Schizophrenia; Treatment Outcome	2006
Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl. Clinical toxicology (Philadelphia, Pa.), 2007, Volume: 45, Issue:3 Topics: Adolescent; Anti-Anxiety Agents; Antidotes; Antipsychotic Agents; Bromocriptine; Clopenthixol; Delayed-Action Preparations; Diazepam; Dopamine Agonists; Female; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Lithium Compounds; Lorazepam; Neuroleptic Malignant Syndrome; Treatment Outcome	2007
Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jun-30, Volume: 31, Issue:5 Topics: Anemia, Hypochromic; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; beta-Thalassemia; Bipolar Disorder; Bromocriptine; Drug Therapy, Combination; Female; Glasgow Coma Scale; Humans; Hypothyroidism; Lithium Compounds; Middle Aged; Neuroleptic Malignant Syndrome; Pneumonia; Risperidone; Venous Thrombosis	2007
Catatonia and neuroleptic malignant syndrome: two sides of a coin? Acta neurologica Belgica, 2007, Volume: 107, Issue:2 Topics: Adult; Aged; Alcoholism; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Brain Injuries; Bromocriptine; Catatonia; Dantrolene; Depression; Dopamine Agonists; Female; Humans; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Psychotic Disorders	2007
Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome. The Journal of the Association of Physicians of India, 2008, Volume: 56 Topics: Adult; Bromocriptine; Dantrolene; Dopamine Agonists; Electroconvulsive Therapy; Female; Humans; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Treatment Outcome	2008
[Association of an acute thyrotoxic crisis and the neuroleptic malignant syndrome. Efficacy of bromocriptine]. Presse medicale (Paris, France : 1983), 1984, Sep-15, Volume: 13, Issue:31 Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Female; Humans; Neuroleptic Malignant Syndrome; Thyroid Crisis	1984
[Acute renal failure in neuroleptic malignant syndrome]. Orvosi hetilap, 1995, Oct-01, Volume: 136, Issue:40 Topics: Acute Kidney Injury; Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Renal Dialysis; Rhabdomyolysis	1995
An atypical course of neuroleptic malignant syndrome. Journal of clinical pharmacology, 1994, Volume: 34, Issue:4 Topics: Amantadine; Bromocriptine; Dantrolene; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Pneumonia, Aspiration; Psychiatric Department, Hospital; Renal Insufficiency; Time Factors	1994
Management of neuroleptic malignant syndrome--a series of eight cases. The Journal of the Association of Physicians of India, 1993, Volume: 41, Issue:2 Topics: Adolescent; Adult; Bromocriptine; Carbidopa; Dantrolene; Dopamine Agents; Drug Combinations; Female; Humans; India; Levodopa; Male; Muscular Diseases; Neuroleptic Malignant Syndrome	1993
Neuroleptic malignant syndrome and clozapine. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1993, Volume: 5, Issue:1 Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dantrolene; Diagnosis, Differential; Fever; Humans; Male; Muscle Rigidity; Neuroleptic Malignant Syndrome; Schizophrenia	1993
The neuroleptic malignant syndrome and acute renal failure. Journal of the American Society of Nephrology : JASN, 1994, Volume: 4, Issue:7 Topics: Acute Kidney Injury; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Fever; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Rhabdomyolysis; Water-Electrolyte Imbalance	1994
Amantadine withdrawal and neuroleptic malignant syndrome. Neurology, 1993, Volume: 43, Issue:10 Topics: Amantadine; Bromocriptine; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome	1993
Neuroleptic malignant syndrome: a dangerous complication of neuroleptic therapy. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1993, Volume: 25, Issue:1 Topics: Adult; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome	1993
[Malignant neuroleptic syndrome treated with bromocriptine]. Revista clinica espanola, 1993, Volume: 192, Issue:1 Topics: Adult; Bromocriptine; Humans; Male; Neuroleptic Malignant Syndrome	1993
[Beneficial effect of bromocriptine in a patient with malignant syndrome and hepatic dysfunctions]. Masui. The Japanese journal of anesthesiology, 1993, Volume: 42, Issue:3 Topics: Adult; Bromocriptine; Humans; Liver Diseases; Male; Neuroleptic Malignant Syndrome	1993
Neuroleptic malignant syndrome: case report in a multiple trauma patient. Injury, 1993, Volume: 24, Issue:3 Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Multiple Trauma; Neuroleptic Malignant Syndrome	1993
Neuroleptic malignant syndrome in a patient with head injury. Intensive care medicine, 1996, Volume: 22, Issue:6 Topics: Adolescent; Bromocriptine; Craniocerebral Trauma; Creatine Kinase; Dantrolene; Hemofiltration; Humans; Male; Multiple Trauma; Neuroleptic Malignant Syndrome; Pancuronium; Rhabdomyolysis	1996
Suspected neuroleptic malignant syndrome in a patient receiving clozapine. The Annals of pharmacotherapy, 1996, Volume: 30, Issue:3 Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dopamine Agonists; Humans; Male; Neuroleptic Malignant Syndrome	1996
[Malignant-like neuroleptic syndrome: a sign to call attention to]. Anales de medicina interna (Madrid, Spain : 1984), 1995, Volume: 12, Issue:9 Topics: Aged; Antiparkinson Agents; Bromocriptine; Cephalosporins; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease	1995
[Neuroleptic malignant syndrome in the elderly: description of 4 patients]. Anales de medicina interna (Madrid, Spain : 1984), 1997, Volume: 14, Issue:8 Topics: Aged; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Neuroleptic Malignant Syndrome	1997
Neuroleptic malignant syndrome in a burn patient. Burns : journal of the International Society for Burn Injuries, 1998, Volume: 24, Issue:6 Topics: Accidents, Occupational; Adult; Antipsychotic Agents; Bromocriptine; Burns; Dantrolene; Debridement; Delirium; Dopamine Agonists; Fever; Follow-Up Studies; Haloperidol; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Psychomotor Agitation; Surgical Wound Infection	1998
[A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation]. Rinsho shinkeigaku = Clinical neurology, 1999, Volume: 39, Issue:6 Topics: Anticoagulants; Antiparkinson Agents; Bromocriptine; Dantrolene; Disseminated Intravascular Coagulation; Female; Gabexate; Humans; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Parkinson Disease; Status Epilepticus	1999
Neuroleptic malignant syndrome in an adolescent head trauma patient. Clinical pediatrics, 1999, Volume: 38, Issue:10 Topics: Accidents, Traffic; Adolescent; Age Factors; Anti-Dyskinesia Agents; Bromocriptine; Craniocerebral Trauma; Dantrolene; Female; Haloperidol; Humans; Motorcycles; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Treatment Outcome	1999
Selective destruction of nigrostriatal dopaminergic neurons does not alter [3H]-ryanodine binding in rat striatum. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2000, Volume: 33, Issue:2 Topics: Adrenergic Agents; Animals; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agonists; Male; Neuroleptic Malignant Syndrome; Neurons; Oxidopamine; Piperazines; Rats; Rats, Wistar; Ryanodine Receptor Calcium Release Channel; Substantia Nigra	2000
Neuroleptic malignant syndrome associated with olanzapine therapy: a case report. The Journal of emergency medicine, 2000, Volume: 19, Issue:4 Topics: Adult; Anti-Bacterial Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Combined Modality Therapy; Cryotherapy; Dantrolene; Dopamine Agonists; Emergency Treatment; Hemiplegia; Humans; Intubation, Intratracheal; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Schizophrenia; Selective Serotonin Reuptake Inhibitors	2000
Neuroleptic malignant syndrome without neuroleptics. Singapore medical journal, 2001, Volume: 42, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Creatine Kinase; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome	2001
Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea. Journal of the National Medical Association, 2002, Volume: 94, Issue:4 Topics: Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Pulmonary Edema	2002
Neuroleptic malignant syndrome in Malaysia: a university hospital experience. The Medical journal of Malaysia, 1992, Volume: 47, Issue:3 Topics: Adolescent; Aged; Antipsychotic Agents; Bromocriptine; Female; Hospitals, University; Humans; Neuroleptic Malignant Syndrome; Retrospective Studies	1992
Lethal catatonia and neuroleptic malignant syndrome. Critical care medicine, 1992, Volume: 20, Issue:11 Topics: Bromocriptine; Catatonia; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrome	1992
Neuroleptic malignant syndrome and its successful treatment with bromocriptine--a case report. JPMA. The Journal of the Pakistan Medical Association, 1991, Volume: 41, Issue:1 Topics: Adult; Antipsychotic Agents; Bromocriptine; Creatine Kinase; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia	1991
[Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases]. Wiener klinische Wochenschrift, 1991, Volume: 103, Issue:1 Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Dantrolene; Depressive Disorder; Diazepam; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Lisuride; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders; Schizophrenia	1991
Drug treatment of the neuroleptic malignant syndrome. Psychopharmacology bulletin, 1991, Volume: 27, Issue:3 Topics: Amantadine; Bromocriptine; Dantrolene; Dihydroxyphenylalanine; Dopamine Agents; Humans; Neuroleptic Malignant Syndrome	1991
Neuroleptic malignant syndrome (a case report). Journal of postgraduate medicine, 1991, Volume: 37, Issue:3 Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Lorazepam; Neuroleptic Malignant Syndrome	1991
The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care? The British journal of psychiatry : the journal of mental science, 1991, Volume: 159 Topics: Adult; Bromocriptine; Combined Modality Therapy; Critical Care; Dantrolene; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Neurologic Examination; Prospective Studies	1991
Neuroleptic malignant syndrome improved by bromocriptine. The Journal of the Association of Physicians of India, 1991, Volume: 39, Issue:4 Topics: Bromocriptine; Humans; Neuroleptic Malignant Syndrome	1991
A hazardous side effect of neuroleptics: diagnosis and treatment. Geriatrics, 1990, Volume: 45, Issue:8 Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome	1990
Bromocriptine and neuroleptic malignant syndrome. The Journal of clinical psychiatry, 1991, Volume: 52, Issue:1 Topics: Bromocriptine; Humans; Neuroleptic Malignant Syndrome	1991
Positron emission tomographic studies of changes in cerebral blood flow and oxygen metabolism in neuroleptic malignant syndrome. European neurology, 1991, Volume: 31, Issue:1 Topics: Adult; Blood Gas Analysis; Brain; Bromocriptine; Cerebrovascular Circulation; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Oxygen Consumption; Tomography, Emission-Computed	1991
Porcine stress syndrome: an animal model for the neuroleptic malignant syndrome? Biological psychiatry, 1990, Jul-01, Volume: 28, Issue:1 Topics: Animals; Brain; Bromocriptine; Disease Models, Animal; Haloperidol; Halothane; Hyperthermia, Induced; Lithium; Lithium Carbonate; Neuroleptic Malignant Syndrome; Pilot Projects; Receptors, Dopamine; Swine; Swine Diseases	1990
Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant. Neurology, 1990, Volume: 40, Issue:11 Topics: Bromocriptine; Dantrolene; Desipramine; Dopamine; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Norepinephrine	1990
[Protracted recurrent neuroleptic malignant syndrome]. Revue neurologique, 1990, Volume: 146, Issue:8-9 Topics: Adult; Bromocriptine; Dantrolene; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Recurrence	1990
Neuroleptic malignant syndrome. The Central African journal of medicine, 1990, Volume: 36, Issue:5 Topics: Adult; Bromocriptine; Chlorpromazine; Dantrolene; Female; Haloperidol; Humans; Lithium; Neuroleptic Malignant Syndrome	1990
[Neuroleptic malignant syndrome--life-threatening but treatable]. Lakartidningen, 1990, May-02, Volume: 87, Issue:18 Topics: Adult; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Prognosis	1990
Neuroleptic malignant syndrome improved by bromocriptine. The Journal of the Association of Physicians of India, 1990, Volume: 38, Issue:5 Topics: Adult; Bromocriptine; Humans; Isoniazid; Male; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced	1990
[Malignant neuroleptic syndrome and malignant hyperthermia--a comparison]. Fortschritte der Neurologie-Psychiatrie, 1986, Volume: 54, Issue:5 Topics: Adult; Amantadine; Bromocriptine; Calcium; Cross-Sectional Studies; Dantrolene; Female; Humans; Ion Channels; Male; Malignant Hyperthermia; Muscle Contraction; Muscular Diseases; Neuroleptic Malignant Syndrome; Risk	1986
Neuroleptic malignant syndrome and psychotic illness. The British journal of psychiatry : the journal of mental science, 1989, Volume: 155 Topics: Adult; Antipsychotic Agents; Bromocriptine; Combined Modality Therapy; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome; Schizophrenia, Catatonic	1989
Neuroleptic malignant syndrome with trifluperidol. The British journal of psychiatry : the journal of mental science, 1989, Volume: 155 Topics: Adult; Bromocriptine; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia; Schizophrenic Psychology; Trifluperidol	1989
Concomitant treatment of neuroleptic malignant syndrome and psychosis. The British journal of psychiatry : the journal of mental science, 1989, Volume: 154 Topics: Adult; Bromocriptine; Creatine Kinase; Humans; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders; Thioridazine	1989
Neuroleptic malignant syndrome. Journal of neurosurgical nursing, 1985, Volume: 17, Issue:6 Topics: Adult; Antipsychotic Agents; Bromocriptine; Catatonia; Diagnosis, Differential; Female; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome	1985
Diagnosing and treating neuroleptic malignant syndrome. The American journal of psychiatry, 1986, Volume: 143, Issue:5 Topics: Antipsychotic Agents; Bromocriptine; Creatine Kinase; Dantrolene; Humans; Muscle Rigidity; Neuroleptic Malignant Syndrome; Terminology as Topic	1986
Rigidity and fever in two psychotic patients. Hospital practice (Office ed.), 1986, Jul-15, Volume: 21, Issue:7 Topics: Adult; Antipsychotic Agents; Bromocriptine; Dantrolene; Fever; Humans; Male; Muscle Rigidity; Neuroleptic Malignant Syndrome; Psychotic Disorders	1986
Therapeutic rounds: neuroleptic malignant syndrome. Clinical therapeutics, 1986, Volume: 8, Issue:6 Topics: Adult; Antipsychotic Agents; Bromocriptine; Catatonia; Diagnosis, Differential; Humans; Male; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary	1986
Neuroleptic malignant syndrome superimposed on tardive dyskinesia. The British journal of psychiatry : the journal of mental science, 1987, Volume: 150 Topics: Adult; Antipsychotic Agents; Bromocriptine; Dyskinesia, Drug-Induced; Humans; Male; Neuroleptic Malignant Syndrome	1987
[Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases]. Der Nervenarzt, 1988, Volume: 59, Issue:2 Topics: Adult; Aged; Antipsychotic Agents; Brain; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary; Receptors, Dopamine; Schizophrenia	1988
Neuroleptic malignant syndrome: guidelines for treatment and reinstitution of neuroleptics. Southern medical journal, 1988, Volume: 81, Issue:7 Topics: Antipsychotic Agents; Bromocriptine; Dantrolene; Diagnosis, Differential; Humans; Neuroleptic Malignant Syndrome	1988
Neuroleptic malignant syndrome. American family physician, 1988, Volume: 38, Issue:5 Topics: Adult; Aged; Bromocriptine; Creatine Kinase; Diagnosis, Differential; Family Practice; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Pneumonia, Pneumococcal	1988
Diagnosis and treatment of neuroleptic malignant syndrome. Clinical pharmacy, 1988, Volume: 7, Issue:9 Topics: Adolescent; Amantadine; Animals; Bromocriptine; Dantrolene; Electroconvulsive Therapy; Female; Humans; Neuroleptic Malignant Syndrome	1988
Emergency treatment of the neuroleptic malignant syndrome. Hawaii medical journal, 1988, Volume: 47, Issue:4 Topics: Adult; Bromocriptine; Clinical Protocols; Dantrolene; Emergencies; Humans; Male; Neuroleptic Malignant Syndrome	1988
Neuroleptic malignant syndrome, bromocriptine, and anticholinergic drugs. The Journal of clinical psychiatry, 1988, Volume: 49, Issue:7 Topics: Adult; Benztropine; Bromocriptine; Drug Therapy, Combination; Humans; Male; Muscle Rigidity; Neuroleptic Malignant Syndrome; Tropanes	1988
Neuroleptic malignant syndrome. The Journal of the Association of Physicians of India, 1987, Volume: 35, Issue:11 Topics: Adult; Bromocriptine; Female; Humans; India; Male; Neuroleptic Malignant Syndrome	1987
The neuroleptic malignant syndrome after open heart surgery: successful treatment with bromocriptine. New York state journal of medicine, 1987, Volume: 87, Issue:6 Topics: Aged; Bromocriptine; Coronary Artery Bypass; Humans; Male; Neuroleptic Malignant Syndrome; Postoperative Complications	1987
Navigating neuroleptic malignant syndrome. The American journal of nursing, 1986, Volume: 86, Issue:6 Topics: Adult; Bromocriptine; Diagnosis, Differential; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic Disorders	1986
Therapy of neuroleptic malignant syndrome. Psychiatric developments, 1986,Spring, Volume: 4, Issue:1 Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine	1986
Successful treatment of neuroleptic malignant syndrome with bromocriptine. Southern medical journal, 1986, Volume: 79, Issue:12 Topics: Administration, Oral; Aged; Body Temperature; Bromocriptine; Creatine Kinase; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome	1986
Bromocriptine treatment of neuroleptic malignant syndrome. The Journal of clinical psychiatry, 1987, Volume: 48, Issue:2 Topics: Adolescent; Adult; Bromocriptine; Creatine Kinase; Drug Evaluation; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Neurologic Examination; Time Factors	1987
Assessing treatment of neuroleptic malignant syndrome. The American journal of psychiatry, 1986, Volume: 143, Issue:1 Topics: Amantadine; Bromocriptine; Cortisone; Drug Therapy, Combination; Humans; Neuroleptic Malignant Syndrome; Piperidines	1986
Neuroleptic malignant syndrome complicating closed head injury. Neurosurgery, 1986, Volume: 18, Issue:2 Topics: Adult; Brain Injuries; Bromocriptine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Psychomotor Agitation; Wounds, Nonpenetrating	1986
[Malignant neuroleptic syndrome: successful treatment of a patient with bromocriptine]. Nederlands tijdschrift voor geneeskunde, 1985, Jan-12, Volume: 129, Issue:2 Topics: Adolescent; Basal Ganglia Diseases; Bromocriptine; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome	1985
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause. Neurology, 1985, Volume: 35, Issue:2 Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine	1985
Dopamine agonists and neuroleptic malignant syndrome. The American journal of psychiatry, 1985, Volume: 142, Issue:2 Topics: Alzheimer Disease; Amantadine; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome	1985
Neuroleptic malignant syndrome. Annals of emergency medicine, 1985, Volume: 14, Issue:4 Topics: Adult; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Diagnosis, Differential; Haloperidol; Heat Exhaustion; Humans; Male; Malignant Hyperthermia; Neuroleptic Malignant Syndrome	1985
Neuroleptic malignant syndrome: successful treatment with bromocriptine. Biological psychiatry, 1985, Volume: 20, Issue:6 Topics: Adolescent; Basal Ganglia Diseases; Bromocriptine; Creatine Kinase; Haloperidol; Homovanillic Acid; Humans; Male; Neuroleptic Malignant Syndrome; Paranoid Disorders; Prolactin; Transaminases	1985